作者:Tara R. Rheault、Thomas R. Caferro、Scott H. Dickerson、Kelly H. Donaldson、Michael D. Gaul、Aaron S. Goetz、Robert J. Mullin、Octerloney B. McDonald、Kimberly G. Petrov、David W. Rusnak、Lisa M. Shewchuk、Glenn M. Spehar、Anne T. Truesdale、Dana E. Vanderwall、Edgar R. Wood、David E. Uehling
DOI:10.1016/j.bmcl.2008.12.011
日期:2009.2
Two new series of potent and selective dual EGFR/ErbB-2 kinase inhibitors derived from novel thienopyrimidine cores have been identified. Isomeric thienopyrimidine cores were evaluated as isosteres for a 4-anilinoquinazoline core and several analogs containing the thieno[3,2-d]pyrimidine core showed anti-proliferative activity with IC50 values less than 1 mu M against human tumor cells in vitro. (C) 2008 Elsevier Ltd. All rights reserved.